Haleon plc (HLN)
NYSE: HLN · Real-Time Price · USD
10.76
+0.32 (3.07%)
At close: Feb 26, 2026, 4:00 PM EST
10.76
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:10 PM EST
Haleon Market Cap
Haleon has a market cap or net worth of $47.44 billion as of February 26, 2026. Its market cap has increased by 6.79% in one year.
Market Cap
47.44B
Enterprise Value
57.36B
1-Year Change
6.79%
Ranking
Category
Stock Price
$10.76
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from $34.14B to $47.44B, an increase of 38.94%. That is a compound annual growth rate of 9.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 45.57B | 1.42% |
| Dec 31, 2025 | 44.93B | 5.03% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
| Jul 18, 2022 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 59.03B |
| Zoetis | 53.10B |
| Teva Pharmaceutical Industries | 39.49B |
| United Therapeutics | 20.43B |
| Viatris | 18.37B |
| Regencell Bioscience Holdings | 13.35B |
| Neurocrine Biosciences | 12.88B |
| Elanco Animal Health | 12.30B |